Search research articles
Contact Us
Filters
Showing results (41-50 of 54) with videos related to
Page
of 6
Sort By:
The Journal of Organic Chemistry
|
April 3, 2001
Total synthesis of the epidermal growth factor inhibitor (-)-reveromycin B
A N Cuzzupe, C A Hutton, M J Lilly, et al.
Clinical Science (London, England : 1979)
|
March 1, 1994
Albumin excretory rate in normal and hypertensive pregnancy
M A Brown, M X Wang, M L Buddle, et al.
Clinical and Experimental Pharmacology & Physiology
|
May 23, 2012
FT23, an orally active antifibrotic compound, attenuates structural and functional abnormalities in an experimental model of diabetic cardiomyopathy
Sih Min Tan, Yuan Zhang, Bing Wang, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 3, 2009
Evaluation and optimization of antifibrotic activity of cinnamoyl anthranilates
Steven C Zammit, Alison J Cox, Renae M Gow, et al.
Oncogene
|
February 19, 1999
Increased expression of fibroblast growth factor 8 in human breast cancer
S K Marsh, G S Bansal, C Zammit, et al.
Plos One
|
October 17, 2012
A purpose-synthesised anti-fibrotic agent attenuates experimental kidney diseases in the rat
Richard E Gilbert, Yuan Zhang, Spencer J Williams, et al.
Physical Review Letters
|
February 22, 2020
Effect of Electron Capture on Spectral Line Broadening in Hot Dense Plasmas
T A Gomez, T Nagayama, C J Fontes, et al.
Clinicoeconomics and Outcomes Research : CEOR
|
February 13, 2015
Estimating the real world daily usage and cost for exenatide twice daily and liraglutide in Germany, the Netherlands, and the UK based on volumes dispensed by pharmacies
Amanda L McDonell, Urpo Kiiskinen, Danielle C Zammit, et al.
Breast (Edinburgh, Scotland)
|
December 11, 2014
A constitutional predisposition to breast cancer-related lymphoedema and effect of axillary lymph node surgery on forearm muscle lymph flow
S K Bains, A W B Stanton, V Cintolesi, et al.
The British Journal of Surgery
|
March 3, 2015
Global abnormalities in lymphatic function following systemic therapy in patients with breast cancer
S K Bains, A M Peters, C Zammit, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 54) with videos related to
Sort By:
Page
of 6
The Journal of Organic Chemistry
|
April 3, 2001
Total synthesis of the epidermal growth factor inhibitor (-)-reveromycin B
A N Cuzzupe, C A Hutton, M J Lilly, et al.
Clinical Science (London, England : 1979)
|
March 1, 1994
Albumin excretory rate in normal and hypertensive pregnancy
M A Brown, M X Wang, M L Buddle, et al.
Clinical and Experimental Pharmacology & Physiology
|
May 23, 2012
FT23, an orally active antifibrotic compound, attenuates structural and functional abnormalities in an experimental model of diabetic cardiomyopathy
Sih Min Tan, Yuan Zhang, Bing Wang, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 3, 2009
Evaluation and optimization of antifibrotic activity of cinnamoyl anthranilates
Steven C Zammit, Alison J Cox, Renae M Gow, et al.
Oncogene
|
February 19, 1999
Increased expression of fibroblast growth factor 8 in human breast cancer
S K Marsh, G S Bansal, C Zammit, et al.
Plos One
|
October 17, 2012
A purpose-synthesised anti-fibrotic agent attenuates experimental kidney diseases in the rat
Richard E Gilbert, Yuan Zhang, Spencer J Williams, et al.
Physical Review Letters
|
February 22, 2020
Effect of Electron Capture on Spectral Line Broadening in Hot Dense Plasmas
T A Gomez, T Nagayama, C J Fontes, et al.
Clinicoeconomics and Outcomes Research : CEOR
|
February 13, 2015
Estimating the real world daily usage and cost for exenatide twice daily and liraglutide in Germany, the Netherlands, and the UK based on volumes dispensed by pharmacies
Amanda L McDonell, Urpo Kiiskinen, Danielle C Zammit, et al.
Breast (Edinburgh, Scotland)
|
December 11, 2014
A constitutional predisposition to breast cancer-related lymphoedema and effect of axillary lymph node surgery on forearm muscle lymph flow
S K Bains, A W B Stanton, V Cintolesi, et al.
The British Journal of Surgery
|
March 3, 2015
Global abnormalities in lymphatic function following systemic therapy in patients with breast cancer
S K Bains, A M Peters, C Zammit, et al.
Page
of 6